Oncología Hepática
University of Birmingham
Birmingham, Reino UnidoUniversity of Birmingham-ko ikertzaileekin lankidetzan egindako argitalpenak (8)
2023
-
Robotic versus laparoscopic liver resection for huge (â¥10 cm) liver tumors: an international multicenter propensity-score matched cohort study of 799 cases
HEPATOBILIARY SURGERY AND NUTRITION, Vol. 12, Núm. 2, pp. 205-216
-
Robotic versus laparoscopic liver resection for huge (â¥10 cm) liver tumors: an international multicenter propensity-score matched cohort study of 799 cases
HEPATOBILIARY SURGERY AND NUTRITION, Vol. 12, Núm. 2, pp. 205-216
2022
-
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma
Clinical Cancer Research, Vol. 28, Núm. 12, pp. 2555-2566
-
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
The Lancet, Vol. 399, Núm. 10319, pp. 61-116
2019
-
Corrigendum to “New vaccination strategies in liver cancer” [Cytokine Growth Factor Rev. 36 (2017) 125–129](S1359610117301089)(10.1016/j.cytogfr.2017.06.010)
Cytokine and Growth Factor Reviews
-
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
Genome Medicine, Vol. 11, Núm. 1
2016
-
Long-term impact of liver function on curative therapy for hepatocellular carcinoma: Application of the ALBI grade
British Journal of Cancer, Vol. 114, Núm. 7, pp. 744-750
2015
-
A nssessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach - The albi grade
Journal of Clinical Oncology, Vol. 33, Núm. 6, pp. 550-558